EarlyCDT-Lung: An immunobiomarker test as an aid to early detection of lung cancer

Cancer Prevention Research

Volumn 4, Issue 7, 2011, Pages 1126-1134

  Lam, Stephen ^a   Boyle, Peter ^b   Healey, Graham F ^c   Maddison, Paul ^d   Peek, Laura ^f   Murray, Andrea ^c   Chapman, Caroline J ^e   Allen, Jared ^c   Wood, William C ^g   Sewell, Herb F ^e   Robertson, John F R ^e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f Oncimmune Germany GmbH   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; PROTEIN P53; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; EARLYCDT LUNG TEST; FEMALE; HUMAN; IMMUNOASSAY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79960076353     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0328     Document Type: Article

References (43)

1. Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, et al. Technical validation of an autoantibody test for lung cancer. Ann Oncol 2010;21:1687-93.
2. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, Wood WC, et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011;22:383-9.
3. Boyle P, Levin B. (Eds). World Cancer Report 2001. IARC Press, Lyon, France.
4. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. (Eds). SEER Cancer Statistics Review 1975-2006. National Cancer Institute. Bethesda, MD. Available from http://seer.cancer.gov/csr/1975-2006/based on November 2008 SEER data submission, posted to the SEER website 2009.
5. Koletsis EN, Prokakis C, Karanikolas M, Apostolakis E, Dougenis D. Current role of surgery in small cell lung carcinoma. J Cardiothorac Surg 2009;4:30.
6. Lim E, Belcher E, Yap YK, Nicholson AG, Goldstraw P. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008;3:1267-71.
7. Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, et al. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 2005;129:64-72. (Pubitemid 40038097)
8. Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242-5. (Pubitemid 28181964)
9. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105. (Pubitemid 29313143)
10. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-65. (Pubitemid 40432263)
11. Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911-20. (Pubitemid 34141832)
12. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer 2001;92:153-9. (Pubitemid 32623052)
13. Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222:773-81. (Pubitemid 34215229)
14. Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002;122:15-20. (Pubitemid 34754137)
15. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-21. (Pubitemid 38943126)
16. McWilliams A, Mayo J, MacDonald S, leRiche JC, Palcic B, Szabo E, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003;168:1167-73. (Pubitemid 37421833)
17. Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
18. Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25-32. (Pubitemid 32102499)
19. Croswell JM, Baker SG, Marcus PM, Clapp JD, Kramer BS. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med 2010;152:505-80.
20. Geyer CJ. Estimation and optimization of functions. In: Markov Chain Monte Carlo in Practice (Eds: WR Gilks, S Richardson and DJ Spiegelhalter). 1996; pp 241-58. Chapman and Hall, London.
21. NCI. Lung cancer trial results show mortality benefit with low-dose CT. http://www.cancer.gov/newscenter/pressreleases/2010/NLSTresultsRelease. Accessed 11 April 2010.
22. Robertson JF, Pearson D, Price MR, Selby C, Badley RA, Pearson J, et al. Assessment of four monoclonal antibodies as serum markers in breast cancer. Eur J Cancer 1990;26:1127-32.
23. Robertson JF, Pearson D, Price MR, Selby C, Pearson J, Blamey RW, et al. Prospective assessment of the role of five tumour markers in breast cancer. Cancer Immunol Immunother 1991;33:403-10.
24. Laurence DJ, Stevens U, Bettelheim R, Darcy D, Leese C, Turberville C, et al. Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinoma. Br Med J 1972;3:605-9.
25. Thomas WM, Robertson JF, Price MR, Hardcastle JD. Failure of CA19-9 to detect asymptomatic colorectal carcinoma. Br J Cancer 1991;63:975-6.
26. Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001;108:1411-5. (Pubitemid 33091976)
27. Houghton AN. Cancer antigens: immune recognition of self and altered self. J Exp Med 1994;180:1-4. (Pubitemid 24181047)
28. Brichory FM, Misek DE, Yim AM, Krause MC, Giordano TJ, Beer DG, et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 2001;98:9824-9. (Pubitemid 32769388)
29. Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev 2003;12:136-43. (Pubitemid 36194003)
30. Nesterova M, Johnson N, Cheadle C, Cho-Chung YS. Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 2006;1762:398-403. (Pubitemid 43344300)
31. Robertson JFR, Chapman C, Cheung K-L, Murray A, Pinder SE, Price MR, et al. Autoantibodies in early breast cancer. J Clin Oncol 2005;23:549.
32. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-9. (Pubitemid 47181397)
33. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, et al. Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 2007;18:868-73. (Pubitemid 47054083)
34. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Tureci O, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-33. (Pubitemid 351373718)
35. Robertson JFR, Graves CRL, Price MR. Tumour Markers US 7,402,403,B1. Nottingham: Onclmmune Ltd. 1999.
36. Chapman CJ, Thorpe AJ, Murray A, Parsky-Kowalska C, Allen J, Stafford K, et al. Immuno-biomarkers in small cell lung cancer: potential early cancer signals. Clin Cancer Res 2011;17:1474-80.
37. Trivers GE, De B V, Cawley HL, Caron G, Harrington AM, Bennett WP, et al. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res 1996;2:1767-75. (Pubitemid 26356363)
38. Li Y, Karjalainen A, Koskinen H, Hemminki K, Vainio H, Shnaidman M, et al. p53 autoantibodies predict subsequent development of cancer. Int J Cancer 2005;114:157-60. (Pubitemid 40194322)
39. Pereira-Faca SR, Kuick R, Puravs E, Zhang Q, Krasnoselsky AL, Phanstiel D, et al. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 2007;67:12000-6.
40. Rohayem J, Diestelkoetter P, Weigle B, Oehmichen A, Schmitz M, Mehlhorn J, et al. Antibody response to the tumor-associated inhibitor of apoptosis protein surviving in cancer patients. Cancer Res 2000;60:1815-7. (Pubitemid 30207636)
41. Suzuki H, Graziano DF, McKolanis J, Finn OJ. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin Cancer Res 2005;11:1521-6. (Pubitemid 40315235)
42. Chapman CJ, Robertson JF, Murray A, Titulaer M, Lang B, Thorpe A, et al. The presence of autoantibodies to tumour-associated antigens can predate clinical diagnosis of small cell lung cancer. Chest 2010;138:775A.
43. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, et al. Lung cancer risk prediction-prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011; In press.